Combined Inhibition of HRAS and MEK Induces Tumor Regression and Restores Myogenic Differentiation in HRAS-Mutant Rhabdomyosarcoma.
Odeniyide, Patience, Alyza Skaist, Elizabeth Fenner, Hanah Amirkhanian, Andrew Baker, Alla Lisok, Lindy Zhang, et al. 2026. “Combined Inhibition of HRAS and MEK Induces Tumor Regression and Restores Myogenic Differentiation in HRAS-Mutant Rhabdomyosarcoma.”. Cancer Research.